| Identification | More | [Name]
1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde | [CAS]
137076-22-3 | [Synonyms]
1-BOC-4-FORMYLPIPERIDINE
1-BOC-4-PIPERIDINECARBOXALDEHYDE
1-N-BOC-4-FORMYLPIPERIDINE
1-TERT-BUTOXYCARBONYLPIPERIDINE-4-CARBOXYL ALDEHYDE
4-FORMYL-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER
N-BOC-4-FORMYLPIPERIDINE
N-BOC-4-PIPERIDINYLCARBOXALDEHYDE
1-N-Boc-4-piperidinecarboxaldehyde
4-Formylpiperidine-1-carboxylicacidtert-butylester95%
N-BOC-PIPERIDINE-4-CARBALDEHYDE
1-(tert-butoxycarbonyl)-4-formylpiperidine
1-BOC-4-FORMYLPIPERIDINE 95%
1-tert-Butoxycarbonyl-4-piperidinecarboxaldehyde
1-TERT-BUTOXYCARBONYLPIPERIDINE-4-CARBOXALDEHYDE
Piperidine-4-carboxaldehyde, N-BOC protected
TERT-BUTYL 4-FORMYLPIPERIDINE-1-CARBOXYLATE
1-Piperidinecarboxylic acid, 4-formyl-, 1,1-dimethylethyl ester | [EINECS(EC#)]
203-107-6 | [Molecular Formula]
C11H19NO3 | [MDL Number]
MFCD02179019 | [Molecular Weight]
213.27 | [MOL File]
137076-22-3.mol |
| Chemical Properties | Back Directory | [Melting point ]
34-40℃ | [Boiling point ]
295.4±33.0 °C(Predicted) | [density ]
1.114±0.06 g/cm3(Predicted) | [Fp ]
>110℃ | [storage temp. ]
2-8°C | [solubility ]
Soluble in methanol. | [form ]
Oil | [pka]
-2.13±0.40(Predicted) | [color ]
Clear Yellow | [Sensitive ]
Air Sensitive | [InChIKey]
JYUQEWCJWDGCRX-UHFFFAOYSA-N | [CAS DataBase Reference]
137076-22-3(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xi | [Risk Statements ]
R36/37/38:Irritating to eyes, respiratory system and skin . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection . | [RIDADR ]
UN 3077 9/PG 3 | [HS Code ]
29333990 |
| Hazard Information | Back Directory | [Chemical Properties]
Clear Yellow Oil | [Uses]
An intermediate for polycyclic indazole derivatives that are ERK inhibitors. | [Uses]
Reactant for synthesis of:• ;Pim-1 inhibitors1• ;Selective GPR119 agonists for type II diabetes2• ;M-tropic (R5) HIV-1 replication inhibitors3• ;HDAC inhibitors4• ;Selective 5-HT6 antagonists5Reactant for three-component vinylogous Mannich reactions6 |
|
|